Hongshan Ge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hongshan Ge has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
Qi Zhu
A Reproductive Medicine Center, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University
12 shared publicationsYu Xiang
Reproduction Medicine Centre, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, China
11 shared publicationsJieyu Cai
Reproduction Medicine Centre, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, People’s Republic of China
10 shared publicationsNa Liang
Reproduction Medicine Centre, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, People’s Republic of China
10 shared publicationsLinglin Weng
Reproduction Medicine Centre, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, People’s Republic of China
9 shared publicationsTianyue Xu
Reproduction Medicine Centre, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China
8 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1879713
Follicular development impairment in polyendocrine metabolic ovarian syndrome: multidimensional pathophysiological networks and frontier therapeutic targets
Polyendocrine metabolic ovarian syndrome (PMOS) is a prevalent endocrine-metabolic disorder characterised by follicular arrest, anovulation, and elevated androgen levels. This review transcends single-dimensional analyses of PMOS pathology from neuroendocrine or metabolic perspectives, proposing an integrated multi-layered network model to systematically elucidate the pathological mechanisms underlying follicular arrest. Post-pubertal dysfunction of the hypothalamic-pituitary-ovarian axis interacts with systemic metabolic dysregulation, jointly establishing an ovarian microenvironment characterised by hyperandrogenism, hyperinsulinaemia, and chronic inflammation. This environment further induces self-reinforcing vicious cycles within follicles, manifesting as impaired granulosa-oocyte communication, immunometabolic reprogramming (e.g., M1 macrophage polarisation), and organelle stress (including mitochondrial dysfunction and endoplasmic reticulum stress). This localised cycle is consolidated and amplified by higher-level regulatory factors—including developmental epigenetic programming, the gut-brain-ovary axis, and circadian rhythms—ultimately establishing a pathologically entrenched state. Finally, this network-based understanding informs future research pathways, focusing on how emerging strategies—such as multi-omics integration, artificial intelligence, and stem cell secretome studies—can advance phenotype-directed precision interventions. This review aims to provide a systematic, dynamic theoretical framework for understanding the complex pathogenesis of PMOS and its potential therapeutic targets.
- 7 October 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1879713
Open AccessFollicular development impairment in polyendocrine metabolic ovarian syndrome: multidimensional pathophysiological networks and frontier therapeutic targets
Polyendocrine metabolic ovarian syndrome (PMOS) is a prevalent endocrine-metabolic disorder characterised by follicular arrest, anovulation, and elevated androgen levels. This review transcends single-dimensional analyses of PMOS pathology from neuroendocrine or metabolic perspectives, proposing an integrated multi-layered network model to systematically elucidate the pathological mechanisms underlying follicular arrest. Post-pubertal dysfunction of the hypothalamic-pituitary-ovarian axis interacts with systemic metabolic dysregulation, jointly establishing an ovarian microenvironment characterised by hyperandrogenism, hyperinsulinaemia, and chronic inflammation. This environment further induces self-reinforcing vicious cycles within follicles, manifesting as impaired granulosa-oocyte communication, immunometabolic reprogramming (e.g., M1 macrophage polarisation), and organelle stress (including mitochondrial dysfunction and endoplasmic reticulum stress). This localised cycle is consolidated and amplified by higher-level regulatory factors—including developmental epigenetic programming, the gut-brain-ovary axis, and circadian rhythms—ultimately establishing a pathologically entrenched state. Finally, this network-based understanding informs future research pathways, focusing on how emerging strategies—such as multi-omics integration, artificial intelligence, and stem cell secretome studies—can advance phenotype-directed precision interventions. This review aims to provide a systematic, dynamic theoretical framework for understanding the complex pathogenesis of PMOS and its potential therapeutic targets.
- Open Access
- 8 September 2026
- Published by Springer Nature in Cell Death Discovery
Lipotoxicity-induced ER-mitochondrial hypercoupling activates the mtDNA-cGAS-STING-NF-κB axis to drive follicular arrest in metabolically compromised PCOS
Polycystic ovary syndrome (PCOS) represents a major cause of anovulatory infertility worldwide, yet the mechanistic nexus linking metabolic perturbations to follicular microenvironment deterioration remains elusive. This study uncovers a novel pathogenic axis wherein lipotoxicity in metabolically compromised PCOS (M-PCOS) patients—irrespective of hyperandrogenemia status—disrupts organelle homeostasis to drive follicular arrest. Integrated analyses of human follicular samples and functional validation in palmitic acid (PA)-treated granulosa cells reveal that lipotoxic stress induces endoplasmic reticulum (ER) stress, triggering ER-mitochondrial hypercoupling and pathological calcium flux. This cascade culminates in mitochondrial permeability transition pore (mPTP)-dependent release of mitochondrial DNA (mtDNA) into the cytosol, where it serves as a potent damage-associated molecular pattern (DAMP) that activates the cGAS-STING-NF-κB inflammatory pathway. Critically, we establish that this pathway operates independently of hyperandrogenemia and represents a core mechanism of granulosa cell dysfunction in M-PCOS. Genetic or pharmacological inhibition of mtDNA release (cyclosporine A), STING signaling (C-176), or ER stress (TUDCA) effectively suppressed the inflammatory cascade and restored cellular homeostasis. Most significantly, melatonin emerged as a superior therapeutic candidate, preserving organelle architecture, preventing calcium dysregulation, blocking mtDNA release, and attenuating inflammation both in vitro and in a PCOS mouse model. These findings redefine our understanding of M-PCOS pathogenesis by establishing lipotoxicity-induced organelle dysfunction as a central driver of follicular arrest, and position melatonin as a clinically translatable therapeutic agent for rescuing follicular development in metabolic PCOS—a population with notoriously poor response to conventional ovulation induction therapies.
- 8 September 2026
- Published by Springer Nature in Cell Death Discovery
Open AccessLipotoxicity-induced ER-mitochondrial hypercoupling activates the mtDNA-cGAS-STING-NF-κB axis to drive follicular arrest in metabolically compromised PCOS
Polycystic ovary syndrome (PCOS) represents a major cause of anovulatory infertility worldwide, yet the mechanistic nexus linking metabolic perturbations to follicular microenvironment deterioration remains elusive. This study uncovers a novel pathogenic axis wherein lipotoxicity in metabolically compromised PCOS (M-PCOS) patients—irrespective of hyperandrogenemia status—disrupts organelle homeostasis to drive follicular arrest. Integrated analyses of human follicular samples and functional validation in palmitic acid (PA)-treated granulosa cells reveal that lipotoxic stress induces endoplasmic reticulum (ER) stress, triggering ER-mitochondrial hypercoupling and pathological calcium flux. This cascade culminates in mitochondrial permeability transition pore (mPTP)-dependent release of mitochondrial DNA (mtDNA) into the cytosol, where it serves as a potent damage-associated molecular pattern (DAMP) that activates the cGAS-STING-NF-κB inflammatory pathway. Critically, we establish that this pathway operates independently of hyperandrogenemia and represents a core mechanism of granulosa cell dysfunction in M-PCOS. Genetic or pharmacological inhibition of mtDNA release (cyclosporine A), STING signaling (C-176), or ER stress (TUDCA) effectively suppressed the inflammatory cascade and restored cellular homeostasis. Most significantly, melatonin emerged as a superior therapeutic candidate, preserving organelle architecture, preventing calcium dysregulation, blocking mtDNA release, and attenuating inflammation both in vitro and in a PCOS mouse model. These findings redefine our understanding of M-PCOS pathogenesis by establishing lipotoxicity-induced organelle dysfunction as a central driver of follicular arrest, and position melatonin as a clinically translatable therapeutic agent for rescuing follicular development in metabolic PCOS—a population with notoriously poor response to conventional ovulation induction therapies.
- Open Access
- 16 July 2026
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 19 (1)
Mendelian randomization in ovarian research: applications in PCOS, ovarian aging, and assisted reproductive technology
Ovarian disorders such as polycystic ovary syndrome (PCOS) and primary ovarian insufficiency (POI) have complex etiologies that are difficult to disentangle using observational studies. Mendelian randomization (MR) offers a powerful approach to identify causal drivers of these conditions, with direct implications for assisted reproductive technology (ART), but its application is blocked by the ART phenotype gap, namely the absence of large-scale GWAS for cycle-specific outcomes. This review synthesizes a conceptual framework to navigate this gap. In the near term, researchers can use existing genetic data through two complementary strategies, upstream exposure analysis and proxy outcome analysis, both requiring rigorous validation and sensitivity testing. In the long term, the field must build deeply phenotyped ART genomic consortia with standardized data and ethical governance. This approach enables causal hypothesis generation using existing data, while recognizing that definitive evidence will require deeply phenotyped consortia in the future.
- 16 July 2026
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 19 (1)
Open AccessMendelian randomization in ovarian research: applications in PCOS, ovarian aging, and assisted reproductive technology
Ovarian disorders such as polycystic ovary syndrome (PCOS) and primary ovarian insufficiency (POI) have complex etiologies that are difficult to disentangle using observational studies. Mendelian randomization (MR) offers a powerful approach to identify causal drivers of these conditions, with direct implications for assisted reproductive technology (ART), but its application is blocked by the ART phenotype gap, namely the absence of large-scale GWAS for cycle-specific outcomes. This review synthesizes a conceptual framework to navigate this gap. In the near term, researchers can use existing genetic data through two complementary strategies, upstream exposure analysis and proxy outcome analysis, both requiring rigorous validation and sensitivity testing. In the long term, the field must build deeply phenotyped ART genomic consortia with standardized data and ethical governance. This approach enables causal hypothesis generation using existing data, while recognizing that definitive evidence will require deeply phenotyped consortia in the future.
- Open Access
- 20 March 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (12) , e48005
Mediating role of the systemic immune-inflammation index in obesity-induced glycolipid dysmetabolism and compromised IVF/ICSI outcomes in polycystic ovary syndrome: A retrospective cohort study
: This study aims to investigate the mediating role of the systemic immune-inflammation index (SII) in the relationship between obesity-related glycolipid indices and in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcomes in women with polycystic ovary syndrome (PCOS). A total of 598 women diagnosed with PCOS according to the Rotterdam criteria and undergoing their first IVF/ICSI cycle at the Reproduction Medicine Center, Taizhou People’s Hospital Affiliated with Nanjing Medical University, Jiangsu, China between January 2021 and December 2023 were included. Key exposures included obesity-related metabolic indices (e.g., triglyceride to high-density lipoprotein ratio [TG/HDL], homeostasis model assessment of insulin resistance [HOMA-IR]) and the SII. The primary outcome was the live birth rate per initiated cycle. Associations were evaluated using multivariate generalized linear models, and causal mediation analysis was performed to quantify the proportion of the effect mediated by the SII. Higher TG/HDL, total cholesterol to HDL ratio (TC/HDL), low-density lipoprotein to HDL ratio (LDL/HDL), and HOMA-IR levels showed dose-dependent negative correlations with oocyte yield, fertilization rate, embryo quality, and live birth rate (all P < .05). An elevated SII was an independent predictor of a reduced live birth rate (β = −0.08, P = .008) and mediated 8.8% to 10.7% of the adverse effects of dyslipidemia (via TC/HDL and LDL/HDL) on live birth. This study shows that the SII is statistically linked to and potentially mediates the connection between metabolic dysfunction and poor IVF/ICSI outcomes in PCOS. Integrated strategies targeting both metabolism and inflammation may optimize fertility success in this population.
- 20 March 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (12) , e48005
Open AccessMediating role of the systemic immune-inflammation index in obesity-induced glycolipid dysmetabolism and compromised IVF/ICSI outcomes in polycystic ovary syndrome: A retrospective cohort study
: This study aims to investigate the mediating role of the systemic immune-inflammation index (SII) in the relationship between obesity-related glycolipid indices and in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcomes in women with polycystic ovary syndrome (PCOS). A total of 598 women diagnosed with PCOS according to the Rotterdam criteria and undergoing their first IVF/ICSI cycle at the Reproduction Medicine Center, Taizhou People’s Hospital Affiliated with Nanjing Medical University, Jiangsu, China between January 2021 and December 2023 were included. Key exposures included obesity-related metabolic indices (e.g., triglyceride to high-density lipoprotein ratio [TG/HDL], homeostasis model assessment of insulin resistance [HOMA-IR]) and the SII. The primary outcome was the live birth rate per initiated cycle. Associations were evaluated using multivariate generalized linear models, and causal mediation analysis was performed to quantify the proportion of the effect mediated by the SII. Higher TG/HDL, total cholesterol to HDL ratio (TC/HDL), low-density lipoprotein to HDL ratio (LDL/HDL), and HOMA-IR levels showed dose-dependent negative correlations with oocyte yield, fertilization rate, embryo quality, and live birth rate (all P < .05). An elevated SII was an independent predictor of a reduced live birth rate (β = −0.08, P = .008) and mediated 8.8% to 10.7% of the adverse effects of dyslipidemia (via TC/HDL and LDL/HDL) on live birth. This study shows that the SII is statistically linked to and potentially mediates the connection between metabolic dysfunction and poor IVF/ICSI outcomes in PCOS. Integrated strategies targeting both metabolism and inflammation may optimize fertility success in this population.
- Open Access
- 21 February 2026
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 19 (1)
Upregulation of mitoNEET disrupts granulosa cell proliferation, apoptosis and mitochondrial homeostasis : a possible pathogenesis of follicular dysplasia in PCOS
Polycystic ovary syndrome (PCOS), a leading cause of anovulatory infertility, is characterized by arrested follicular development due to imbalanced prolife
- 21 February 2026
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 19 (1)
Open AccessUpregulation of mitoNEET disrupts granulosa cell proliferation, apoptosis and mitochondrial homeostasis : a possible pathogenesis of follicular dysplasia in PCOS
Polycystic ovary syndrome (PCOS), a leading cause of anovulatory infertility, is characterized by arrested follicular development due to imbalanced prolife
- Open Access
- 13 February 2026
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 19 (1)
Cell-free DNA in female infertility: from pathological mechanisms to clinical biomarkers
Female infertility, accounting for 40–50% of infertility cases globally, underscores the urgent need for non-invasive biomarkers to guide early intervention. Cell-free DNA (cfDNA)—released via apoptosis, necrosis, or active secretion—has emerged as a dynamic molecular reflector of tissue pathophysiology. This review synthesizes recent advances in cfDNA biology and their clinical applications in female infertility. Mechanistically, cfDNA drives inflammation, oxidative stress, and neutrophil extracellular traps (NETs), exacerbating dysfunction in polycystic ovary syndrome (PCOS), endometriosis (EMs), and premature ovarian insufficiency (POI). Clinically, cfDNA characteristics in follicular fluid or plasma serve as diagnostic-prognostic tools: reduced mitochondrial cfDNA (cf-mtDNA) in PCOS signifies oocyte mitochondrial damage; elevated long-fragment ratios in EMs/POI reflect chronic inflammation; and low cfDNA integrity in assisted reproductive technology (ART) predicts poor embryo quality. Despite challenges in standardization and ethics, future integration with multi-omics platforms is poised to translate cfDNA analysis into precision reproductive medicine.
- 13 February 2026
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 19 (1)
Open AccessCell-free DNA in female infertility: from pathological mechanisms to clinical biomarkers
Female infertility, accounting for 40–50% of infertility cases globally, underscores the urgent need for non-invasive biomarkers to guide early intervention. Cell-free DNA (cfDNA)—released via apoptosis, necrosis, or active secretion—has emerged as a dynamic molecular reflector of tissue pathophysiology. This review synthesizes recent advances in cfDNA biology and their clinical applications in female infertility. Mechanistically, cfDNA drives inflammation, oxidative stress, and neutrophil extracellular traps (NETs), exacerbating dysfunction in polycystic ovary syndrome (PCOS), endometriosis (EMs), and premature ovarian insufficiency (POI). Clinically, cfDNA characteristics in follicular fluid or plasma serve as diagnostic-prognostic tools: reduced mitochondrial cfDNA (cf-mtDNA) in PCOS signifies oocyte mitochondrial damage; elevated long-fragment ratios in EMs/POI reflect chronic inflammation; and low cfDNA integrity in assisted reproductive technology (ART) predicts poor embryo quality. Despite challenges in standardization and ethics, future integration with multi-omics platforms is poised to translate cfDNA analysis into precision reproductive medicine.
- Open Access
- 2 September 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 3014
Identifying critical windows of air pollution exposure and semen quality: A cross-sectional study in Chinese fertile men
Although human studies on the hazard that air pollution represents to male reproductive health, there are wide variations in exposure concentration, key components, semen quality indicators and the identification of susceptible exposure windows. The study aimed to further explore the relationship between air pollution and semen quality and the more accurate sensitive exposure windows. We investigated a cross-sectional study consisting of 1554 fertile men from Nanjing, China and evaluated their exposure to PM10, PM2.5, CO, SO2, NO2 and O3 in the air. Multiple linear regression was utilized to estimate the correlation between weekly air pollution exposure and semen quality, as well as weighted quantile sum (WQS) regression and bayesian kernel machine regression (BKMR) for the effect of mixtures. We also established the distributed lag non-linear model to delineate exposure-lag-response relationship. Our analysis linked PM2.5 exposure at week 10 to reduced total motility (β = - 2.06, 95% CI: (- 3.71, - 0.41)) and progressive motility (β = - 1.79, 95% CI: (- 3.23, - 0.34)). WQS regression showed co-exposure inversely correlated with total motility (β = - 1.49, 95% CI: (- 2.63, - 0.35)) and progressive motility (β = - 1.27, 95% CI: (- 2.30, - 0.25)) at week 11, where PM2.5 contributed the most. A great lagged impact resulting from PM2.5 on sperm motility peaked 10 to 11 weeks after exposure. We also found that PM2.5 exposure at week 10 increased the risk of having below-referenced progressive motility (< 32%) by the method of BKMR. Based on these results, the early stage of spermatogenesis (from week 10 to week 11 before semen collection), was recognized as the susceptible exposure window. Furthermore, BKMR analysis suggested co-exposure to major components of the primary contributor, PM2.5, during this period were negatively correlated with sperm motility, including NO3-, NH4+, SO42-, black carbon and organic matter, and SO42- was the most weighted composition. In both the single pollutant models and the multi-pollutants models, PM2.5 and its chemical components inversely correlated with sperm motility in a relatively early window (from week 10 to week 11 before semen collection) which was identified to be more sensitive to air pollution.
- 2 September 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 3014
Open AccessIdentifying critical windows of air pollution exposure and semen quality: A cross-sectional study in Chinese fertile men
Although human studies on the hazard that air pollution represents to male reproductive health, there are wide variations in exposure concentration, key components, semen quality indicators and the identification of susceptible exposure windows. The study aimed to further explore the relationship between air pollution and semen quality and the more accurate sensitive exposure windows. We investigated a cross-sectional study consisting of 1554 fertile men from Nanjing, China and evaluated their exposure to PM10, PM2.5, CO, SO2, NO2 and O3 in the air. Multiple linear regression was utilized to estimate the correlation between weekly air pollution exposure and semen quality, as well as weighted quantile sum (WQS) regression and bayesian kernel machine regression (BKMR) for the effect of mixtures. We also established the distributed lag non-linear model to delineate exposure-lag-response relationship. Our analysis linked PM2.5 exposure at week 10 to reduced total motility (β = - 2.06, 95% CI: (- 3.71, - 0.41)) and progressive motility (β = - 1.79, 95% CI: (- 3.23, - 0.34)). WQS regression showed co-exposure inversely correlated with total motility (β = - 1.49, 95% CI: (- 2.63, - 0.35)) and progressive motility (β = - 1.27, 95% CI: (- 2.30, - 0.25)) at week 11, where PM2.5 contributed the most. A great lagged impact resulting from PM2.5 on sperm motility peaked 10 to 11 weeks after exposure. We also found that PM2.5 exposure at week 10 increased the risk of having below-referenced progressive motility (< 32%) by the method of BKMR. Based on these results, the early stage of spermatogenesis (from week 10 to week 11 before semen collection), was recognized as the susceptible exposure window. Furthermore, BKMR analysis suggested co-exposure to major components of the primary contributor, PM2.5, during this period were negatively correlated with sperm motility, including NO3-, NH4+, SO42-, black carbon and organic matter, and SO42- was the most weighted composition. In both the single pollutant models and the multi-pollutants models, PM2.5 and its chemical components inversely correlated with sperm motility in a relatively early window (from week 10 to week 11 before semen collection) which was identified to be more sensitive to air pollution.
- 13 August 2025
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 52 (4) , 105215
Iron dysmetabolism in ovarian follicles: implications for oocyte quality and embryo development in endometriosis
- 13 August 2025
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 52 (4) , 105215
Iron dysmetabolism in ovarian follicles: implications for oocyte quality and embryo development in endometriosis
- Open Access
- 30 July 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1) , 1-15
Hyperandrogenism-mediated YAP activation drives ovarian inflammation and pyroptosis in PCOS: implications for follicular dysfunction
Hyperandrogenism and persistent chronic inflammation significantly contribute to ovarian dysfunction in polycystic ovary syndrome (PCOS). Although the exact connection between hyperandrogenism and inflammation in PCOS remains unclear, the Hippo pathway, also seems to be involved in the inflammatory response through YAP. An in-vivo PCOS model of mice was constructed with dehydroepiandrosterone (DHEA) and YAP inhibitor Verteporfin (VP). YAP, inflammation and pyroptosis levels of ovarian tissues were detected in mice models. An in-vitro PCOS model of KGN cells was constructed with testosterone, and YAP was knocked down by lentivirus. Increased levels of YAP in the ovarian tissues of the DHEA-treated mice were observed, alongside elevations in inflammation and pyroptosis levels, whereas Verteporfin reversed these alterations. The findings in KGN cells demonstrated that testosterone treatment results in elevation of YAP, inflammation and pyroptosis levels in granulosa cells. However, knocking down YAP in KGN cells curtailed testosterone-induced inflammation and pyroptosis. Hyperandrogenism in PCOS promotes ovarian inflammation by upregulating nuclear YAP, disrupting the inflammatory microenvironment, leading to abnormal ovarian pyroptosis, and ultimately impairing follicular function.
- 30 July 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1) , 1-15
Open AccessHyperandrogenism-mediated YAP activation drives ovarian inflammation and pyroptosis in PCOS: implications for follicular dysfunction
Hyperandrogenism and persistent chronic inflammation significantly contribute to ovarian dysfunction in polycystic ovary syndrome (PCOS). Although the exact connection between hyperandrogenism and inflammation in PCOS remains unclear, the Hippo pathway, also seems to be involved in the inflammatory response through YAP. An in-vivo PCOS model of mice was constructed with dehydroepiandrosterone (DHEA) and YAP inhibitor Verteporfin (VP). YAP, inflammation and pyroptosis levels of ovarian tissues were detected in mice models. An in-vitro PCOS model of KGN cells was constructed with testosterone, and YAP was knocked down by lentivirus. Increased levels of YAP in the ovarian tissues of the DHEA-treated mice were observed, alongside elevations in inflammation and pyroptosis levels, whereas Verteporfin reversed these alterations. The findings in KGN cells demonstrated that testosterone treatment results in elevation of YAP, inflammation and pyroptosis levels in granulosa cells. However, knocking down YAP in KGN cells curtailed testosterone-induced inflammation and pyroptosis. Hyperandrogenism in PCOS promotes ovarian inflammation by upregulating nuclear YAP, disrupting the inflammatory microenvironment, leading to abnormal ovarian pyroptosis, and ultimately impairing follicular function.